Renaissance Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.3M | Sell |
153,106
-3,348
| -2% | -$743K | 1.39% | 21 |
|
|
2025
Q4 | $35.7M | Sell |
156,454
-1,494
| -0.9% | -$340K | 1.44% | 25 |
|
|
2025
Q3 | $36.6M | Buy |
157,948
+9,453
| +6% | +$1.92M | 1.38% | 23 |
|
|
2025
Q2 | $27.6M | Sell |
148,495
-3,467
| -2% | -$644K | 1.07% | 53 |
|
|
2025
Q1 | $31.8M | Buy |
151,962
+147,449
| +3,267% | +$28.7M | 1.4% | 28 |
|
|
2024
Q4 | $802K | Sell |
4,513
-546
| -11% | -$100K | 0.03% | 178 |
|
|
2024
Q3 | $999K | Buy |
5,059
+1,705
| +51% | +$318K | 0.04% | 172 |
|
|
2024
Q2 | $575K | Buy |
3,354
+24
| +0.7% | +$3.98K | 0.02% | 225 |
|
|
2024
Q1 | $606K | Sell |
3,330
-58
| -2% | -$10K | 0.02% | 220 |
|
|
2023
Q4 | $525K | Sell |
3,388
-725
| -18% | -$106K | 0.02% | 220 |
|
|
2023
Q3 | $613K | Sell |
4,113
-40
| -1% | -$5.87K | 0.03% | 217 |
|
|
2023
Q2 | $560K | Sell |
4,153
-463
| -10% | -$67.9K | 0.02% | 221 |
|
|
2023
Q1 | $736K | Sell |
4,616
-840
| -15% | -$128K | 0.03% | 216 |
|
|
2022
Q4 | $882K | Sell |
5,456
-1,661
| -23% | -$255K | 0.04% | 209 |
|
|
2022
Q3 | $955K | Sell |
7,117
-537
| -7% | -$77.1K | 0.05% | 199 |
|
|
2022
Q2 | $1.17M | Sell |
7,654
-94
| -1% | -$14.4K | 0.06% | 164 |
|
|
2022
Q1 | $1.26M | Sell |
7,748
-80
| -1% | -$11.6K | 0.06% | 152 |
|
|
2021
Q4 | $1.06M | Sell |
7,828
-249,920
| -97% | -$29.5M | 0.04% | 182 |
|
|
2021
Q3 | $27.8M | Buy |
257,748
+6,138
| +2% | +$701K | 1.2% | 44 |
|
|
2021
Q2 | $28.3M | Sell |
251,610
-4,883
| -2% | -$550K | 1.19% | 45 |
|
|
2021
Q1 | $27.8M | Sell |
256,493
-4,100
| -2% | -$439K | 1.17% | 43 |
|
|
2020
Q4 | $27.9M | Sell |
260,593
-9,567
| -4% | -$919K | 1.2% | 36 |
|
|
2020
Q3 | $23.7M | Sell |
270,160
-8,002
| -3% | -$753K | 1.09% | 52 |
|
|
2020
Q2 | $27.3M | Sell |
278,162
-9,443
| -3% | -$831K | 1.3% | 24 |
|
|
2020
Q1 | $21.9M | Sell |
287,605
-5,996
| -2% | -$511K | 1.22% | 27 |
|
|
2019
Q4 | $26M | Buy |
293,601
+7,170
| +3% | +$595K | 1.07% | 45 |
|
|
2019
Q3 | $21.7M | Sell |
286,431
-1,465
| -0.5% | -$100K | 0.92% | 55 |
|
|
2019
Q2 | $20.9M | Buy |
287,896
+37,580
| +15% | +$2.95M | 0.85% | 55 |
|
|
2019
Q1 | $20.2M | Buy |
250,316
+21,328
| +9% | +$1.74M | 0.81% | 55 |
|
|
2018
Q4 | $21.1M | Sell |
228,988
-52,511
| -19% | -$4.62M | 0.97% | 38 |
|
|
2018
Q3 | $26.6M | Buy |
281,499
+9,277
| +3% | +$880K | 0.93% | 51 |
|
|
2018
Q2 | $25.2M | Buy |
272,222
+6,186
| +2% | +$604K | 0.9% | 52 |
|
|
2018
Q1 | $25.2M | Buy |
+266,036
| New | +$29.2M | 0.86% | 55 |
|
Other funds holding ABBV
VCM
VPM
Renaissance Group's ABBV Position: Q1 2026 in Review
Renaissance Group reduced its AbbVie (ABBV) stake by 2.1% in Q1 2026, selling an estimated $743K and leaving 153,106 shares worth $33.3M. The position accounts for 1.39% of the portfolio, ranked #21.
Renaissance Group first reported a position in ABBV in Q1 2018 and has held it in 33 quarters since. The position peaked at $36.6M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Renaissance Group held 153,106 shares of AbbVie worth $33.3M as of Q1 2026.
- Renaissance Group sold 3,348 AbbVie shares in Q1 2026, an estimated $743K.
- AbbVie made up 1.39% of Renaissance Group's portfolio in Q1 2026, its #21 holding.
- Renaissance Group first reported a position in AbbVie in Q1 2018 and has held it in 33 quarters since.
- Renaissance Group's AbbVie position peaked at $36.6M in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Renaissance Group's 13F filing for Q1 2026, filed 13 May 2026.